Neuroparasitic Infections: Cestodes, Trematodes, and Protozoans

M. D. Walker; J. R. Zunt

doi:10.1055/s-2005-917663

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2005; 25(3): 262-277
DOI: 10.1055/s-2005-917663

Neuroparasitic Infections: Cestodes, Trematodes, and Protozoans

M. D. Walker¹ , J. R. Zunt¹ ^, ²

¹Department of Neurology, University of Washington School of Medicine, Seattle, Washington
²Center for AIDS and STD, University of Washington School of Medicine, Seattle, Washington

Abstract

ABSTRACT

Parasitic infection of the nervous system can produce a variety of symptoms and signs. Because symptoms of infection are often mild or nonspecific, diagnosis can be difficult. Familiarity with basic epidemiological characteristics and distinguishing radiographic findings can increase the likelihood of detection and proper treatment of parasitic infection of the nervous system. This article discusses the clinical presentation, diagnosis, and treatment for some of the more common infections of the nervous system caused by cestodes, trematodes and protozoans: Echinococcus spp., Spirometra spp. (sparganosis), Paragonimus spp., Schistosoma spp., Trypanosoma spp., Naegleria fowlerii, Acanthamoeba histolytica, and Balamuthia mandrillaris.

KEYWORDS

Parasite - nervous system - cestodes - trematode - protozoan

Volltext

Referenzen

REFERENCES

1 Algros M P, Majo F, Bresson-Hadni S et al.. Intracerebral alveolar echinococcosis. Infection. 2003; 31 63-65
2 Al Zain T J, Al-Witry S H, Khalili H M et al.. Multiple intracranial hydatidosis. Acta Neurochir (Wien). 2002; 144 1179-1185
3 Lewall D B. Hydatid disease: biology, pathology, imaging and classification. Clin Radiol. 1998; 53 863-874
4 Kern P, Bardonnet K, Renner E et al.. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis. 2003; 9 343-349
5 Bouree P. Hydatidosis: dynamics of transmission. World J Surg. 2001; 25 4-9
6 Garret M, Herbsman H, Fierst S. Cytologic diagnosis of echinococcosis. Acta Cytol. 1977; 21 553-554
7 Farmer P M, Chatterley S, Spier N. Echinococcal cyst of the liver: diagnosis and surgical management. Ann Clin Lab Sci. 1990; 20 385-391
8 Gottstein B, Reichen J. Hydatid lung disease (echinococcosis/hydatidosis). Clin Chest Med. 2002; 23 397-408
9 Ramadan N I, Abel Aaty H E, Mahmoud M S, El Nori A. An enzyme-linked immunoelectrotransfer blot assay for diagnosis of human cystic echinococcosis. J Egypt Soc Parasitol. 1999; 29 849-857
10 Jiang L, Wen H, Ito A. Immunodiagnostic differentiation of alveolar and cystic echinococcosis using ELISA test with 18-kDa antigen extracted from Echinococcus protoscoleces. Trans R Soc Trop Med Hyg. 2001; 95 285-288
11 Kanwar J R, Kaushik S P, Sawhney I M et al.. Specific antibodies in serum of patients with hydatidosis recognised by immunoblotting. J Med Microbiol. 1992; 36 46-51
12 Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev. 1992; 5 248-261
13 Tuzun M, Altinors N, Arda I S, Hekimoglu B. Cerebral hydatid disease CT and MR findings. Clin Imaging. 2002; 26 353-357
14 CDC .DPDx Laboratory diagnosis of parasites of public health concern. Vol. 2003: Centers for Disease Control and Prevention 2003
15 el-Mufti M, Kamag A, Ibrahim H et al.. Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases. Ann Trop Med Parasitol. 1993; 87 241-246
16 Lee K J, Bae Y T, Kim D H et al.. A seroepidemiologic survey for human sparganosis in Gangweon-do. Korean J Parasitol. 2002; 40 177-180
17 Landero A, Hernandez F, Abasolo M A et al.. Cerebral sparganosis caused by Spirometra mansonoides. Case report. J Neurosurg. 1991; 75 472-474
18 Noya O, Alarcon de Noya B, Arrechedera H et al.. Sparganum proliferum: an overview of its structure and ultrastructure. Int J Parasitol. 1992; 22 631-640
19 Fontan R, Beauchamp F, Beaver P C. [New helminthiases in Laos. II. Plathelminths]. Bull Soc Pathol Exot Filiales. 1975; 68 566-573
20 Li X. Food-borne parasitic zoonoses in the People's Republic of China. Southeast Asian J Trop Med Public Health. 1991; 22(suppl) 31-35
21 Hughes A J, Biggs B A. Parasitic worms of the central nervous system: an Australian perspective. Intern Med J. 2002; 32 541-553
22 Schmid H, Watschinger H. Sparganosis in the Masailand. Acta Trop. 1972; 29 218-230
23 Moulinier R, Martinez E, Torres J et al.. Human proliferative sparganosis in Venezuela: report of a case. Am J Trop Med Hyg. 1982; 31 358-363
24 Cummings T J, Madden J F, Gray L et al.. Parasitic lesion of the insula suggesting cerebral sparganosis: case report. Neuroradiology. 2000; 42 206-208
25 Gray M L, Rogers F, Little S et al.. Sparganosis in feral hogs (Sus scrofa) from Florida. J Am Vet Med Assoc. 1999; 215 204-208
26 Park H Y, Lee S U, Kim S H et al.. Epidemiological significance of sero-positive inhabitants against sparganum in Kangwon-do, Korea. Yonsei Med J. 2001; 42 371-374
27 Mastura A B, Ambu S, Hasnah O, Rosli R. Spargana infection of frogs in Malaysia. Southeast Asian J Trop Med Public Health. 1996; 27 51-52
28 Tsou M H, Huang T W. Pathology of subcutaneous sparganosis: report of two cases. J Formos Med Assoc. 1993; 92 649-653
29 Kron M A, Guderian R, Guevara A, Hidalgo A. Abdominal sparganosis in Ecuador: a case report. Am J Trop Med Hyg. 1991; 44 146-150
30 Rywlin A M, Beck J W, Snyder G B. Sparganosis in Florida. Arch Dermatol. 1968; 97 425-427
31 Norman S H, Kreutner Jr A. Sparganosis: clinical and pathologic observations in ten cases. South Med J. 1980; 73 297-300
32 Taylor R L. Sparganosis in the United States. Report of a case. Am J Clin Pathol. 1976; 66 560-564
33 Mueller J F. Potential longevity of life history stages of Spirometra spp. J Parasitol. 1974; 60 376-377
34 Chang J H, Lin O S, Yeh K T. Subcutaneous sparganosis-a case report and a review of human sparganosis in Taiwan. Kaohsiung J Med Sci. 1999; 15 567-571
35 Pampiglione S, Fioravanti M L, Rivasi F. Human sparganosis in Italy. Case report and review of the European cases. APMIS. 2003; 111 349-354
36 Chang K H, Chi J G, Cho S Y et al.. Cerebral sparganosis: analysis of 34 cases with emphasis on CT features. Neuroradiology. 1992; 34 1-8
37 Botterel F, Bouree P. Ocular sparganosis: a case report. J Travel Med. 2003; 10 245-246
38 Campbell E W, Beals C. Striking eosinophilia in sparganosis. Postgrad Med. 1977; 62 138-140
39 Fan K J, Pezeshkpour G H. Cerebral sparganosis. Neurology. 1986; 36 1249-1251
40 Sarma D P, Weilbaecher T G. Human sparganosis. J Am Acad Dermatol. 1986; 15 1145-1148
41 Nishiyama T, Ide T, Himes Jr S R et al.. Immunodiagnosis of human sparganosis mansoni by micro-chemiluminescence enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg. 1994; 88 663-665
42 Moon W K, Chang K H, Cho S Y et al.. Cerebral sparganosis: MR imaging versus CT features. Radiology. 1993; 188 751-757
43 Jeong S C, Bae J C, Hwang S H et al.. Cerebral sparganosis with intracerebral hemorrhage: a case report. Neurology. 1998; 50 503-506
44 Han S R, Park J K, Kim Y I, Son B C. Posterior cerebral artery infarction caused by cerebral sparganosis-induced vasculitis. Eur Neurol. 2001; 46 105-107
45 Ishii H, Mukae H, Inoue Y et al.. A rare case of eosinophilic pleuritis due to sparganosis. Intern Med. 2001; 40 783-785
46 Kim D G, Paek S H, Chang K H et al.. Cerebral sparganosis: clinical manifestations, treatment, and outcome. J Neurosurg. 1996; 85 1066-1071
47 Torres J R, Noya O O, Noya B A et al.. Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans R Soc Trop Med Hyg. 1981; 75 846-847
48 Blair D, Xu Z B, Agatsuma T. Paragonimiasis and the genus Paragonimus. Adv Parasitol. 1999; 42 113-222
49 Kim D C. Paragonimus westermani: life cycle, intermediate hosts, transmission to man and geographical distribution in Korea. Arzneimittelforschung. 1984; 34 1180-1183
50 Miyazaki I, Hirose H. Immature lung flukes first found in the muscle of the wild boar in Japan. J Parasitol. 1976; 62 836-837
51 Choi W Y. Paragonimus westermani: pathogenesis and clinical features of infection. Arzneimittelforschung. 1984; 34 1184-1185
52 Oh S J. Cerebral and spinal paragonimiasis. A histopathological study. J Neurol Sci. 1969; 9 205-236
53 Kusner D J, King C H. Cerebral paragonimiasis. Semin Neurol. 1993; 13 201-208
54 Ashitani J, Kumamoto K, Matsukura S. Paragonimiasis westermani with multifocal lesions in lungs and skin. Intern Med. 2000; 39 433-436
55 Kagawa F T. Pulmonary paragonimiasis. Semin Respir Infect. 1997; 12 149-158
56 Kang S Y, Kim T K, Kim T Y et al.. A case of chronic cerebral paragonimiasis westermani. Korean J Parasitol. 2000; 38 167-171
57 Kan H, Ogata T, Taniyama A et al.. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani. Pediatrics. 1995; 96 351-354
58 Kim T Y, Joo I J, Kang S Y et al.. Recombinant Paragonimus westermani yolk ferritin is a useful serodiagnostic antigen. J Infect Dis. 2002; 185 1373-1375
59 Oh S J. Paragonimus meningitis. J Neurol Sci. 1968; 6 419-433
60 Yoshida M, Moritaka K, Kuga S, Anegawa S. CT findings of cerebral paragonimiasis in the chronic state. J Comput Assist Tomogr. 1982; 6 195-196
61 Udaka F, Okuda B, Okada M et al.. CT findings of cerebral paragonimiasis in the chronic state. Neuroradiology. 1988; 30 31-34
62 El-Garem A A. Schistosomiasis. Digestion. 1998; 59 589-605
63 Pittella J E. Neuroschistosomiasis. Brain Pathol. 1997; 7 649-662
64 Zheng J, Gu X G, Xu Y L et al.. Relationship between the transmission of schistosomiasis japonica and the construction of the Three Gorge Reservoir. Acta Trop. 2002; 82 147-156
65 Babiker S M, Blankespoor H D, Wassila M et al.. Transmission of Schistosoma haematobium in North Gezira, Sudan. J Trop Med Hyg. 1985; 88 65-73
66 Liu L X. Spinal and cerebral schistosomiasis. Semin Neurol. 1993; 13 189-200
67 Pollner J H, Schwartz A, Kobrine A, Parenti D M. Cerebral schistosomiasis caused by Schistosoma haematobium: case report. Clin Infect Dis. 1994; 18 354-357
68 Haedicke T A. Cerebral schistosomiasis. A report of 10 cases caused by Schistosomiasis japonica. Minn Med. 1972; 55 1105-1114
69 Pittella J E. The relation between involvement of the central nervous system in schistosomiasis mansoni and the clinical forms of the parasitosis. A review. J Trop Med Hyg. 1991; 94 15-21
70 Scrimgeour E M, Gajdusek D C. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain. 1985; 108 1023-1038
71 File S. Interaction of schistosome eggs with vascular endothelium. J Parasitol. 1995; 81 234-238
72 Stuiver P C. Acute schistosomiasis (Katayama fever). Br Med J (Clin Res Ed). 1984; 288 221-222
73 King C H, Mahmoud A A. Drugs five years later: praziquantel. Ann Intern Med. 1989; 110 290-296
74 Jukes M C, Nokes C A, Alcock K J et al.. Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren. Trop Med Int Health. 2002; 7 104-117
75 Brinkmann U K, Powollik W, Werler C, Traore M. An evaluation of sampling methods within communities and the validity of parasitological examination techniques in the field. Trop Med Parasitol. 1988; 39 162-166
76 Ferrari T C, Moreira P R, Oliveira R C et al.. The value of an enzyme-linked immunosorbent assay for the diagnosis of schistosomiasis mansoni myeloradiculopathy. Trans R Soc Trop Med Hyg. 1995; 89 496-500
77 Gjerde I O, Mork S, Larsen J L et al.. Cerebral schistosomiasis presenting as a brain tumor. Eur Neurol. 1984; 23 229-236
78 Fowler R, Lee C, Keystone J S. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg. 1999; 61 47-50
79 Ching H T, Clark A E, Hendrix V J et al.. MR imaging appearance of intracerebral schistosomiasis. AJR Am J Roentgenol. 1994; 162 693-694
80 Preidler K W, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance. AJNR Am J Neuroradiol. 1996; 17 1598-1600
81 Kardaman M W, Amin M A, Fenwick A et al.. A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan. Ann Trop Med Parasitol. 1983; 77 297-304
82 Watt G, Adapon B, Long G W et al.. Praziquantel in treatment of cerebral schistosomiasis. Lancet. 1986; 2 529-532
83 Ferrari M L, Coelho P M, Antunes C M et al.. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ. 2003; 81 190-196
84 Xiao S, Tanner M, N'Goran E K et al.. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 2002; 82 175-181
85 Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz. 2003; 98 577-591
86 Busch M P, Kleinman S H, Nemo G J. Current and emerging infectious risks of blood transfusions. JAMA. 2003; 289 959-962
87 Dias J C, Silveira A C, Schofield C J. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz. 2002; 97 603-612
88 Leiby D A, Herron Jr R M, Read E J et al.. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion. 2002; 42 549-555
89 Sanchez-Guillen M C, Barnabe C, Guegan J F et al.. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. Mem Inst Oswaldo Cruz. 2002; 97 947-952
90 Leiguarda R, Roncoroni A, Taratuto A L et al.. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 1990; 40 850-851
91 Kirk M L, Schofield C J. Density-dependent timing of defaecation by Rhodnius prolixus, and its implications for the transmission of Trypanosoma cruzi. Trans R Soc Trop Med Hyg. 1987; 81 348-349
92 Hall B F, Joiner K A. Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences. J Eukaryot Microbiol. 1993; 40 207-213
93 Anez N, Carrasco H, Parada H et al.. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am J Trop Med Hyg. 1999; 60 215-222
94 Delaporte F. Romana's sign. J Hist Biol. 1997; 30 357-366
95 Dias J C. [Cecilio Romana, Romana's sign and Chagas' disease]. Rev Soc Bras Med Trop. 1997; 30 407-413
96 Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001; 1 92-100
97 Bestetti R B, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997; 60 187-193
98 Matsumoto T K, Hoshino-Shimizu S, Nakamura P M et al.. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease. J Clin Microbiol. 1993; 31 1486-1492
99 Umezawa E S, Nascimento M S, Stolf A M. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease. Diagn Microbiol Infect Dis. 2001; 39 169-176
100 Di Lorenzo G A, Pagano M A, Taratuto A L et al.. Chagasic granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings. J Neuroimaging. 1996; 6 94-97
101 Urbina J A. Specific treatment of Chagas disease: current status and new developments. Curr Opin Infect Dis. 2001; 14 733-741
102 Rodriques Coura J, de Castro S L. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002; 97 3-24
103 Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J. 1994; 127 151-162
104 Cerisola J A, Neves da Silva N, Prata A et al.. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)]. Bol Chil Parasitol. 1977; 32 51-62
105 Smith D H, Pepin J, Stich A H. Human African trypanosomiasis: an emerging public health crisis. Br Med Bull. 1998; 54 341-355
106 Van Nieuwenhove S, Betu-Ku-Mesu V K, Diabakana P M et al.. Sleeping sickness resurgence in the DRC: the past decade. Trop Med Int Health. 2001; 6 335-341
107 Welburn S C, Fevre E M, Coleman P G et al.. Sleeping sickness: a tale of two diseases. Trends Parasitol. 2001; 17 19-24
108 McGovern T W, Williams W, Fitzpatrick J E et al.. Cutaneous manifestations of African trypanosomiasis. Arch Dermatol. 1995; 131 1178-1182
109 Kristensson K, Mhlanga J D, Bentivoglio M. Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions. Curr Top Microbiol Immunol. 2002; 265 227-257
110 Villanueva M S. Trypanosomiasis of the central nervous system. Semin Neurol. 1993; 13 209-218
111 Enanga B, Burchmore R J, Stewart M L, Barrett M P. Sleeping sickness and the brain. Cell Mol Life Sci. 2002; 59 845-858
112 Mhlanga J D, Bentivoglio M, Kristensson K. Neurobiology of cerebral malaria and African sleeping sickness. Brain Res Bull. 1997; 44 579-589
113 Lejon V, Buscher P. Stage determination and follow-up in sleeping sickness. Med Trop (Mars). 2001; 61 355-360
114 Gill D S, Chatha D S, del Carpio-O'Donovan R. MR imaging findings in African trypansomiasis. AJNR Am J Neuroradiol. 2003; 24 1383-1385
115 Nok A J. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res. 2003; 90 71-79
116 Matovu E, Enyaru J C, Legros D et al.. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health. 2001; 6 407-411
117 Docampo R, Moreno S N. Current chemotherapy of human African trypanosomiasis. Parasitol Res. 2003; 90(suppl 1) S10-S13
118 Parija S C, Jayakeerthee S R. Naegleria fowleri: a free living amoeba of emerging medical importance. J Commun Dis. 1999; 31 153-159
119 Gyori E. December 2002: 19-year old male with febrile illness after jet ski accident. Brain Pathol. 2003; 13 237-239
120 Jain R, Prabhakar S, Modi M et al.. Naegleria meningitis: a rare survival. Neurol India. 2002; 50 470-472
121 Barnett N D, Kaplan A M, Hopkin R J et al.. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr Neurol. 1996; 15 230-234
122 Martinez A J. Free-living amebic meningoencephalitides: comparative study. Neurol Neurocir Psiquiatr. 1977; 18 391-401
123 Carter R F. Primary amoebic meningo-encephalitis: clinical, pathological and epidemiological features of six fatal cases. J Pathol Bacteriol. 1968; 96 1-25
124 Viriyavejakul P, Rochanawutanon M, Sirinavin S. Naegleria meningomyeloencephalitis. Southeast Asian J Trop Med Public Health. 1997; 28 237-240
125 Reveiller F L, Cabanes P A, Marciano-Cabral F. Development of a nested PCR assay to detect the pathogenic free-living amoeba Naegleria fowleri. Parasitol Res. 2002; 88 443-450
126 Schumacher D J, Tien R D, Lane K. Neuroimaging findings in rare amebic infections of the central nervous system. AJNR Am J Neuroradiol. 1995; 16 930-935
127 Ferrante A. Free-living amoebae: pathogenicity and immunity. Parasite Immunol. 1991; 13 31-47
128 Loschiavo F, Ventura-Spagnolo T, Sessa E, Bramanti P. Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome. Acta Neurol (Napoli). 1993; 15 333-340
129 Seidel J S, Harmatz P, Visvesvara G S et al.. Successful treatment of primary amebic meningoencephalitis. N Engl J Med. 1982; 306 346-348
130 Sell J J, Rupp F W, Orrison Jr W W. Granulomatous amebic encephalitis caused by acanthamoeba. Neuroradiology. 1997; 39 434-436
131 Deol I, Robledo L, Meza A et al.. Encephalitis due to a free-living amoeba (Balamuthia mandrillaris): case report with literature review. Surg Neurol. 2000; 53 611-616
132 Healy J F. Balamuthia amebic encephalitis: radiographic and pathologic findings. AJNR Am J Neuroradiol. 2002; 23 486-489
133 McCulley J P, Alizadeh H, Niederkorn J Y. The diagnosis and management of Acanthamoeba keratitis. CLAO J. 2000; 26 47-51
134 Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003; 16 273-307
135 Denney C F, Iragui V J, Uber-Zak L D et al.. Amebic meningoencephalitis caused by Balamuthia mandrillaris: case report and review. Clin Infect Dis. 1997; 25 1354-1358
136 Martinez A J, Visvesvara G S. Free-living, amphizoic and opportunistic amebas. Brain Pathol. 1997; 7 583-598
137 Singhal T, Bajpai A, Kalra V et al.. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr Infect Dis J. 2001; 20 623-627

Joseph R ZuntM.D. M.P.H.

Department of Neurology, Harborview Medical Center

Box 359775, 325 Ninth Avenue South

Seattle, WA 98104